News
Vanrafia, 2nd drug in Novartis' IgAN troika, crosses FDA finish line in payday for Chinook investors
When Novartis bought kidney disease biotech Chinook Therapeutics in 2023 for $3.2 billion upfront, the deal included a ...
Vanrafia (atrasentan) is the first drug in the selective endothelin A receptor antagonist (ERA) class to be cleared in the US ...
13d
Pharmaceutical Technology on MSNFDA grants accelerated approval to Novartis’ Vanrafia for IgANThe FDA has granted accelerated approval to Novartis’ Vanrafia for adults with primary immunoglobulin A nephropathy (IgAN).
“We are grateful for the IgAN community’s strong interest in the clinical development of atacicept that helped drive us ...
Vanrafia reduces proteinuria in adults with primary immunoglobulin A nephropathy (IgAN). It has a wholesale acquisition cost ...
IgAN research, focusing on real-world patient experiences, reveals unmet needs in disease education, affordability, and care navigationEXTON, PA, April 08, 2025 (GLOBE NEWSWIRE) -- Spherix Global ...
The Igan Sunset Tanto in Assassin's Creed Shadows is a legendary weapon that can be unlocked by looting certain chests.
The A True Igan quest in Assassin's Creed Shadows picks up just east of your hideout and leans heavily into stealth, eavesdropping, and a bit of climbing.
Spherix Global Insights has released the first edition of its new Patient Dynamixâ„¢: IgA Nephropathy (US) series, delivering a comprehensive look at ...
Check out these picture books, early chapter books and middle-grade books for kids, coming out in spring 2025!
Edgar Lerma, MD, provides insights into the pathophysiology of IgA nephropathy (IgAN) and the therapeutic promise of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results